Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fournier Gangrene × Daptomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Infections 3 Neutropenia 2 Soft Tissue Infections 1 Lymphoma, Follicular 1 Hot Flashes 1 Hematologic Neoplasms 1 Fournier Gangrene 1 Fever 1 Fasciitis, Necrotizing 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00261807 2022-01-27

Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections

University of Maryland, Baltimore

Phase NA Completed

25 enrolled 7 charts

Infections, Lymphoma, Follicular, Soft Tissue Infections, Fournier Gangrene, Fasciitis, Necrotizing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡